Cell Biotech Co., Ltd. (KOSDAQ:049960)
South Korea
· Delayed Price · Currency is KRW 16,200
-20 (-0.12%)
At close: Apr 28, 2026
Cell Biotech Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 111,076 | 89,724 | 97,662 | 76,789 | 86,918 | 133,300 | Upgrade
|
| Market Cap Growth | 30.68% | -8.13% | 27.18% | -11.65% | -34.80% | -19.84% | Upgrade
|
| Enterprise Value | 18,440 | 1,343 | 19,190 | 10,612 | 22,959 | 70,193 | Upgrade
|
| Last Close Price | 16230.00 | 13110.00 | 13643.66 | 10388.77 | 11289.59 | 16183.18 | Upgrade
|
| PE Ratio | 10.97 | 8.86 | 6.46 | 12.18 | 10.50 | 12.84 | Upgrade
|
| Forward PE | - | 8.16 | 8.16 | 8.16 | 8.16 | 8.16 | Upgrade
|
| PS Ratio | 2.09 | 1.69 | 1.96 | 1.43 | 1.72 | 2.84 | Upgrade
|
| PB Ratio | 0.84 | 0.68 | 0.79 | 0.69 | 0.80 | 1.25 | Upgrade
|
| P/TBV Ratio | 0.85 | 0.69 | 0.80 | 0.70 | 0.82 | 1.27 | Upgrade
|
| P/FCF Ratio | 13.88 | 11.21 | 5.38 | 12.26 | 8.32 | 9.49 | Upgrade
|
| P/OCF Ratio | 10.00 | 8.08 | 5.07 | 9.82 | 6.78 | 8.95 | Upgrade
|
| EV/Sales Ratio | 0.35 | 0.03 | 0.38 | 0.20 | 0.45 | 1.50 | Upgrade
|
| EV/EBITDA Ratio | 1.60 | 0.12 | 1.80 | 1.74 | 2.37 | 6.36 | Upgrade
|
| EV/EBIT Ratio | 2.33 | 0.17 | 2.82 | 4.83 | 3.79 | 9.67 | Upgrade
|
| EV/FCF Ratio | 2.30 | 0.17 | 1.06 | 1.69 | 2.20 | 5.00 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.04 | 0.04 | 0.10 | 0.25 | 0.10 | 0.07 | Upgrade
|
| Debt / FCF Ratio | 0.05 | 0.05 | 0.06 | 0.25 | 0.09 | 0.06 | Upgrade
|
| Net Debt / Equity Ratio | -0.70 | -0.70 | -0.70 | -0.61 | -0.60 | -0.53 | Upgrade
|
| Net Debt / EBITDA Ratio | -8.04 | -8.04 | -8.10 | -11.28 | -6.65 | -5.16 | Upgrade
|
| Net Debt / FCF Ratio | -11.57 | -11.57 | -4.76 | -10.98 | -6.17 | -4.06 | Upgrade
|
| Asset Turnover | 0.40 | 0.40 | 0.40 | 0.46 | 0.44 | 0.43 | Upgrade
|
| Inventory Turnover | 3.35 | 3.35 | 3.39 | 3.68 | 3.34 | 3.21 | Upgrade
|
| Quick Ratio | 20.19 | 20.19 | 15.71 | 15.74 | 9.54 | 10.89 | Upgrade
|
| Current Ratio | 21.34 | 21.34 | 16.57 | 16.99 | 10.24 | 11.71 | Upgrade
|
| Return on Equity (ROE) | 7.92% | 7.92% | 12.82% | 5.73% | 7.71% | 10.05% | Upgrade
|
| Return on Assets (ROA) | 3.71% | 3.71% | 3.43% | 1.18% | 3.31% | 4.16% | Upgrade
|
| Return on Invested Capital (ROIC) | 18.32% | 18.56% | 16.29% | 4.63% | 10.55% | 12.97% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.00% | 6.00% | 5.50% | 1.90% | 5.60% | 6.80% | Upgrade
|
| Earnings Yield | 9.12% | 11.29% | 15.49% | 8.21% | 9.53% | 7.79% | Upgrade
|
| FCF Yield | 7.21% | 8.92% | 18.57% | 8.16% | 12.02% | 10.54% | Upgrade
|
| Dividend Yield | 3.70% | - | - | 4.33% | 3.99% | 2.78% | Upgrade
|
| Payout Ratio | 30.42% | 30.42% | 20.36% | 48.86% | 38.43% | 30.65% | Upgrade
|
| Buyback Yield / Dilution | -0.02% | -0.02% | -0.01% | 0.73% | 2.50% | 0.32% | Upgrade
|
| Total Shareholder Return | 3.68% | -0.02% | -0.01% | 5.07% | 6.49% | 3.10% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.